drugset / Trial / NCT00002881
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
Phase 3
Completed
Eastern Cooperative Oncology Group
Cancer and Leukemia Group B · collabNational Cancer Institute (NCI) · collabSWOG Cancer Research Network · collab
RandomizedTreatment
Summary
RATIONALE: Hormone therapy may be an effective treatment for prostate cancer. PURPOSE: Randomized phase III trial to evaluate the effectiveness of treatment with flutamide and suramin with or without hydrocortisone in men who have metastatic or recurrent prostate cancer.
Timeline
- Start
- 1996-10
- Primary completion
- 1998-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flutamide | Small molecule | — | — |
| Subject | Goserelin | Other / unclassified | — | — |
| Subject | Leuprolide | Other / unclassified | — | — |
| Subject | suramin | Small molecule | — | — |
| Background | Hydrocortisone | Other / unclassified | — | — |